We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$10.3B
AUM Growth
+$4.59B
(+80%)
Cap. Flow
+$3.41B
Cap. Flow
% of AUM
32.95%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
970
New
347
Increased
294
Reduced
63
Closed
219
Avg Time Held Equity + Options
1.3
quarters
Top 10 Avg Time Held Equity + Options
1
quarter
Top 20 Avg Time Held Equity + Options
1.6
quarters
Avg Time Held Equity only
1.3
quarters
Top 10 Avg Time Held Equity only
1
quarter
Top 20 Avg Time Held Equity only
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$230M |
| 2 |
NLSN
Nielsen Holdings plc
NLSN
|
+$110M |
| 3 |
Brightstar Lottery PLC
BRSL
|
+$98M |
| 4 |
FDO
FAMILY DOLLAR STORES
FDO
|
+$96.8M |
| 5 |
GE Aerospace
GE
|
+$92.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$142M |
| 2 |
PROTECTIVE LIFE CORP
PL
|
+$135M |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$129M |
| 4 |
AGN
Allergan Inc
AGN
|
+$97.8M |
| 5 |
CVD
COVANCE INC.
CVD
|
+$84.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.85% |
| 2 | Industrials | 15.86% |
| 3 | Consumer Discretionary | 15.68% |
| 4 | Consumer Staples | 11.68% |
| 5 | Technology | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HTS
651
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $384K | ﹤0.01% |
21,108
+7,171
| +51% | +$131K |
2014 Q4
1 quarter
|
|
652
Star Bulk Carriers
SBLK
$3.47B
| $363K | ﹤0.01% |
+20,000
| New | +$426K |
2015 Q1
0 quarters
|
|
|
ESND
653
DELISTED
Essendant Inc.
ESND
| $359K | ﹤0.01% |
+8,750
| New | +$356K |
2015 Q1
0 quarters
|
|
654
Kestrel Group
KG
$37.9M
| $358K | ﹤0.01% |
1,206
+603
| +100% | +$166K |
2014 Q4
1 quarter
|
|
655
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.19B
| $356K | ﹤0.01% |
+312,500
| New | +$60.6M |
2015 Q1
0 quarters
|
|
656
Ascendis Pharma A/S
ASND
$15B
| $354K | ﹤0.01% |
+20,456
| New | +$372K |
2015 Q1
0 quarters
|
|
657
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $332K | ﹤0.01% |
+200,000
| New | +$4.62M |
2015 Q1
0 quarters
|
|
658
HP
HPQ
$26.8B
| $326K | ﹤0.01% |
23,004
+2,244
| +11% | +$37K |
2014 Q4
1 quarter
|
|
659
PUT
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $316K | ﹤0.01% |
+620,000
| New | +$24.7M |
2015 Q1
0 quarters
|
|
660
PUT
United States Oil Fund
USO
$1.95B
| $316K | ﹤0.01% |
+62,500
| New | +$9M |
2015 Q1
0 quarters
|
|
|
BEE
661
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $308K | ﹤0.01% |
24,800
+12,940
| +109% | +$170K |
2014 Q4
1 quarter
|
|
662
PUT
Rio Tinto
RIO
$154B
| $298K | ﹤0.01% |
+940,400
| New | +$42.5M |
2015 Q1
0 quarters
|
|
663
Rithm Property Trust
RPT
$83M
| $290K | ﹤0.01% |
+3,450
| New | +$286K |
2015 Q1
0 quarters
|
|
|
TIVO
664
DELISTED
TIVO INC
TIVO
| $288K | ﹤0.01% |
+27,120
| New | +$293K |
2015 Q1
0 quarters
|
|
665
CareDx
CDNA
$3.26B
| $278K | ﹤0.01% |
50,000
+25,000
| +100% | +$165K |
2014 Q4
1 quarter
|
|
666
DELISTED
Stein Mart Inc
SMRT
| $272K | ﹤0.01% |
+21,922
| New | +$310K |
2015 Q1
0 quarters
|
|
|
AKS
667
CALL
DELISTED
AK Steel Holding Corp
AKS
| $264K | ﹤0.01% |
+2,381,000
| New | +$10.4M |
2015 Q1
0 quarters
|
|
|
EOX
668
DELISTED
EMERALD OIL INC (MT)
EOX
| $257K | ﹤0.01% |
17,334
+4,478
| +35% | +$87.8K |
2013 Q2
7 quarters
|
|
669
ON Semiconductor
ON
$30B
| $250K | ﹤0.01% |
20,630
-7,677
| -27% | -$88K |
2014 Q2
3 quarters
|
|
670
Cineverse
CNVS
$44.9M
| $227K | ﹤0.01% |
700
| – | – |
2014 Q1
4 quarters
|
|
|
CYHHZ
671
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
| $221K | ﹤0.01% |
10,047,894
+5,041,594
| +101% | +$128K |
2014 Q1
4 quarters
|
|
|
AGN
672
DELISTED
Allergan plc
AGN
| $219K | ﹤0.01% |
+735
| New | +$210K |
2015 Q1
0 quarters
|
|
|
FMSA
673
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $217K | ﹤0.01% |
+30,000
| New | +$184K |
2015 Q1
0 quarters
|
|
674
Archrock
AROC
$5.29B
| $212K | ﹤0.01% |
+6,321
| New | +$193K |
2015 Q1
0 quarters
|
|
675
Nuwellis
NUWE
$2.14M
| – | – |
0
| – | – |
2013 Q2
7 quarters
|
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2015 Portfolio in Review
As of Q1 2015, UBS O'Connor held 970 positions worth $10.3B, up 80% from $5.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS O'Connor deployed $3.41B of net new capital in Q1 2015, opening 347 new positions and adding to 294 existing holdings. Its largest new stake was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Humana, an estimated $57.6M trimmed.
- UBS O'Connor's largest Q1 2015 buy was SALIX PHARMACEUTICALS LTD DEL: 1,567,292 shares worth $271M.
- UBS O'Connor added most to Nielsen Holdings plc in Q1 2015, an estimated $110M increase.
- UBS O'Connor's biggest Q1 2015 reduction was Humana, cutting an estimated $57.6M.
- UBS O'Connor fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $142M.
- UBS O'Connor's ten largest holdings make up 18% of its $10.3B portfolio in Q1 2015.
- UBS O'Connor opened 347 new positions and closed 219 in Q1 2015.
- UBS O'Connor's portfolio value rose 80% quarter-over-quarter to $10.3B.
Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.